» Articles » PMID: 34656483

Contrast Ultrasound, Sonothrombolysis and Sonoperfusion In Cardiovascular Disease: Shifting to Theragnostic Clinical Trials

Overview
Publisher Elsevier
Date 2021 Oct 17
PMID 34656483
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Contrast ultrasound has a variety of applications in cardiovascular medicine, both in diagnosing cardiovascular disease as well as providing prognostic information. Visualization of intravascular contrast microbubbles is based on acoustic cavitation, the characteristic oscillation that results in changes in the reflected ultrasound waves. At high power, this acoustic response generates sufficient shear that is capable of enhancing endothelium-dependent perfusion in atherothrombotic cardiovascular disease (sonoperfusion). The oscillation and collapse of microbubbles in response to ultrasound also induces microstreaming and jetting that can fragment thrombus (sonothrombolysis). Several preclinical studies have focused on identifying optimal diagnostic ultrasound settings and treatment regimens. Clinical trials have been performed in acute myocardial infarction, stroke, and peripheral arterial disease often with improved outcome. In the coming years, results of ongoing clinical trials along with innovation and improvements in sonothrombolysis and sonoperfusion will determine whether this theragnostic technique will become a valuable addition to reperfusion therapy.

Citing Articles

Theoretical and Experimental Studies of the Dynamic Damage of Endothelial Cellular Networks Under Ultrasound Cavitation.

Xia C, Hu J, Zhou K, Li Y, Yuan S, Li Q Cell Mol Bioeng. 2025; 18(1):15-28.

PMID: 39949493 PMC: 11813858. DOI: 10.1007/s12195-024-00834-x.


Targeting Reactive Oxygen Species for Diagnosis of Various Diseases.

Lee M, Lee D, Choi D, Kim K, Kang P J Funct Biomater. 2024; 15(12).

PMID: 39728178 PMC: 11677255. DOI: 10.3390/jfb15120378.


Clinical Applications of Micro/Nanobubble Technology in Neurological Diseases.

Patel P, Latt S, Ravi K, Razavi M Biomimetics (Basel). 2024; 9(10).

PMID: 39451851 PMC: 11506587. DOI: 10.3390/biomimetics9100645.


pH-Responsive Theranostic Colloidosome Drug Carriers Enable Real-Time Imaging of Targeted Thrombolytic Process with Near-Infrared-II for Deep Venous Thrombosis.

Ye Y, Chen Z, Zhang S, Slezak P, Lu F, Xie R Research (Wash D C). 2024; 7:0388.

PMID: 38812529 PMC: 11136571. DOI: 10.34133/research.0388.


Interventional thrombus modification in STEMI.

Walsh J, Kotronias R, Banning A, De Maria G Nat Rev Cardiol. 2024; 21(7):435-436.

PMID: 38565957 DOI: 10.1038/s41569-024-01020-2.


References
1.
Belcik J, Davidson B, Xie A, Wu M, Yadava M, Qi Y . Augmentation of Muscle Blood Flow by Ultrasound Cavitation Is Mediated by ATP and Purinergic Signaling. Circulation. 2017; 135(13):1240-1252. PMC: 5373943. DOI: 10.1161/CIRCULATIONAHA.116.024826. View

2.
Datta S, Coussios C, Ammi A, Mast T, de Courten-Myers G, Holland C . Ultrasound-enhanced thrombolysis using Definity as a cavitation nucleation agent. Ultrasound Med Biol. 2008; 34(9):1421-33. PMC: 2945910. DOI: 10.1016/j.ultrasmedbio.2008.01.016. View

3.
Bekeredjian R, Grayburn P, Shohet R . Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol. 2005; 45(3):329-35. DOI: 10.1016/j.jacc.2004.08.067. View

4.
Mathias Jr W, Tsutsui J, Tavares B, Fava A, Aguiar M, Borges B . Sonothrombolysis in ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention. J Am Coll Cardiol. 2019; 73(22):2832-2842. DOI: 10.1016/j.jacc.2019.03.006. View

5.
Muller M, Belcik T, Hodovan J, Ozawa K, Brown E, Powers J . Augmentation of Tissue Perfusion with Contrast Ultrasound: Influence of Three-Dimensional Beam Geometry and Conducted Vasodilation. J Am Soc Echocardiogr. 2021; 34(8):887-895. PMC: 8349774. DOI: 10.1016/j.echo.2021.02.018. View